By Devika Patel
Knoxville, Tenn., Jan. 28 - Resverlogix Corp. said it has completed a C$13 million private placement of units. The deal priced for C$5 million on Dec. 23.
The company sold units of one common share and one quarter-share warrant at C$2.50 per unit. The whole warrants will be exercisable at C$2.50 until Dec. 18, 2011.
Based in Calgary, Alta., Resverlogix is a biotechnology company focused on therapies for cardiovascular disease.
| Issuer: | Resverlogix Corp.
|
| Issue: | Units of one common share and one quarter-share warrant
|
| Amount: | C$13 million
|
| Price: | C$2.50
|
| Warrants: | One quarter-share warrant per unit
|
| Warrant expiration: | Dec. 18, 2011
|
| Warrant strike price: | C$2.50
|
| Pricing date: | Dec. 23
|
| Settlement date: | Jan. 28
|
| Stock symbol: | Toronto: RVX
|
| Stock price: | C$2.65 at close Dec. 22
|
| Market capitalization: | $106 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
